Intesa invests 360 million euros to manage its entire health insurance business

Published Date: 08 Mar 2023

Italy's biggest conglomerate, Intesa Sanpaolo, has paid 360 million euros ($382 million) in cash to acquire a 26.2% stake in health insurer Intesa Sanpaolo RBM Salute, which it does not own. that it will be used.

Read Full News

Latest News

WHO Flags Growing Health Workforce Gap as Workers and Patients Age

The World Health Organization warned on Friday of a gap ⁠in the medical workforce around the world in the 2030s, with a quarter ⁠of doctors set to retire in the next...

Doctors Are Leaning Into Anti-Hustle Vacations

Some doctors are trading crammed itineraries for something radical on vacation: doing absolutely nothing at all.

The Market Forces Quietly Adding Thousands to Patient Bills

Over the past decade, the number of doctors working for hospitals rather than in private practice has more than doubled.

FDA Clears First Standalone Robotic Blood Draw System

A new robotic system is drawing blood in adult patients, but its real-world impact may depend on how often it skips difficult veins.

Med Students’ Secret Weapon? Sleep

Rather than cramming for med school exams all night with little sleep, med students should know that sleep is the key to better learning and memorizing new information.

Oncology Firm Novocure Says Cyberattack Exposed US Patient Records

Oncology company Novocure said on Tuesday a cybersecurity incident involving unauthorized ⁠access to certain information systems in mid-August exposed internal records of...

Todays Updates

Understanding the Long-Term Effects of Traumatic Brain Injury in Military Personnel: Clayton Mucha, MD Louie Pasculli, Clayton Mucha, MD

In honor of Veterans Day, Clayton Mucha, DO, neurorehabilitation physiatrist at Burke Rehabilitation in New York, discusses the lasting effects of traumatic brain injury in military personnel.

GV101 Gains FDA Fast Track Status for Friedreich Ataxia Ahead of Phase 2 Trial Isabella Ciccone, MPH

GV101 receives FDA fast track designation for the treatment of Friedreich ataxia, with a phase 2 trial planned to begin enrollment in late 2026.

FDA Grants Fast Track Status to FRP-003 for Long COVID Ahead of Phase 2 Study Isabella Ciccone, MPH

The FDA granted fast track designation to FRP-003, an investigational oral botanical drug candidate for Long COVID, ahead of a planned phase 2 trial evaluating fatigue in approximately 220 adults.

Awareness, Not Access, Remains the Barrier to NF1 Therapy Marco Meglio

At a NeurologyLive Clinical Forum in Phoenix, Kevin J. Bielamowicz, MD, of Arkansas Children’s Hospital, discussed how a lack of adult neuro-oncology infrastructure is shaping how NF1-associated plexiform neurofibromas get recognized, referred, and treated.

Headlining Current Advances and Challenges in Multiple Sclerosis Care Robert Bermel, MD, Louie Pasculli

Robert Bermel, MD, discusses advances in disease-modifying therapies, the challenges of monitoring MS progression, and emerging biomarkers and treatments that may address remaining unmet needs.

Q&A: Healthy Skin Month—What Clinicians Should Watch in Skin Cancer Care

Q&A: Healthy Skin Month—What Clinicians Should Watch in Skin Cancer Care

Todays Updates

Understanding the Long-Term Effects of Traumatic Brain Injury in Military Personnel: Clayton Mucha, MD Louie Pasculli, Clayton Mucha, MD

In honor of Veterans Day, Clayton Mucha, DO, neurorehabilitation physiatrist at Burke Rehabilitation in New York, discusses the lasting effects of traumatic brain injury in military personnel.

GV101 Gains FDA Fast Track Status for Friedreich Ataxia Ahead of Phase 2 Trial Isabella Ciccone, MPH

GV101 receives FDA fast track designation for the treatment of Friedreich ataxia, with a phase 2 trial planned to begin enrollment in late 2026.

FDA Grants Fast Track Status to FRP-003 for Long COVID Ahead of Phase 2 Study Isabella Ciccone, MPH

The FDA granted fast track designation to FRP-003, an investigational oral botanical drug candidate for Long COVID, ahead of a planned phase 2 trial evaluating fatigue in approximately 220 adults.

Awareness, Not Access, Remains the Barrier to NF1 Therapy Marco Meglio

At a NeurologyLive Clinical Forum in Phoenix, Kevin J. Bielamowicz, MD, of Arkansas Children’s Hospital, discussed how a lack of adult neuro-oncology infrastructure is shaping how NF1-associated plexiform neurofibromas get recognized, referred, and treated.

Headlining Current Advances and Challenges in Multiple Sclerosis Care Robert Bermel, MD, Louie Pasculli

Robert Bermel, MD, discusses advances in disease-modifying therapies, the challenges of monitoring MS progression, and emerging biomarkers and treatments that may address remaining unmet needs.

Q&A: Healthy Skin Month—What Clinicians Should Watch in Skin Cancer Care

Q&A: Healthy Skin Month—What Clinicians Should Watch in Skin Cancer Care

Latest News

The World Health Organization warned on Friday of a gap ⁠in the medical workforce around the world in the 2030s, with a quarter ⁠of doctors set to retire in the next...

Some doctors are trading crammed itineraries for something radical on vacation: doing absolutely nothing at all.

Over the past decade, the number of doctors working for hospitals rather than in private practice has more than doubled.

A new robotic system is drawing blood in adult patients, but its real-world impact may depend on how often it skips difficult veins.

Rather than cramming for med school exams all night with little sleep, med students should know that sleep is the key to better learning and memorizing new information.

Oncology company Novocure said on Tuesday a cybersecurity incident involving unauthorized ⁠access to certain information systems in mid-August exposed internal records of...

News All Time

Where Have All the Leaders Gone? PAs Want to Step Up

Many PAs are well qualified for leadership roles, but organizational barriers and limited opportunities continue to stand in the way.

CMS Proposes Major Medicare Physician Payment Overhaul to Boost Primary Care

The Centers for Medicare & Medicaid Services on Tuesday proposed changes to Medicare's decades-old physician payment system, saying the ⁠updates would support the Trump...

Married to Medicine: The Other Side of the Story

Being married to a doctor isn’t the easiest job. These doctors’ spouses share what it’s like and where to get support.

Cigna Invests $100 Million in New AI-powered Specialty Pharmacy Program

Cigna said on Wednesday its health services unit Evernorth has launched a new ⁠AI-powered specialty pharmacy program to reduce the time it takes to process prescriptions and...

Resident Doctors in England Vote for UK Government's Pay Offer, Ending Strikes

Resident doctors in England have voted to accept the government's latest pay and job offer, their ⁠union said on Monday, bringing an end to a long-running industrial dispute...

Democratic-led States Sue Over Trump Administration's Medicaid Work Requirement Rule

A coalition of Democratic-led states sued on Monday to block a Trump administration rule implementing new work requirements for Medicaid recipients, ⁠arguing it unlawfully...

Trump Cuts New York Funding for Medicaid Fraud Unit

The Trump administration said on Tuesday it would cut off funding to ⁠New York's Medicaid fraud unit, accusing it of underperforming in a move that could jeopardize the...

Europe Must Rethink Medicine Pricing or Risk Losing Investment

Europe will need to rethink how it values and pays for innovative ⁠medicines or risk losing manufacturing investments and clinical trials, the head of Europe's pharmaceutical industry lobby said.

Medicare AI Creates Errors and Delays for Patients, Doctors

Patients, doctors, and other healthcare professionals who spoke with KFF Health News say the effort has created confusion, errors, long wait times, and stress.

Analysis-Big Pharma Taps UK Playbook to Pressure European Capitals on Drug Prices

Global pharmaceutical companies, facing pushback from European capitals on drug pricing, are turning to a playbook that brought them recent success in Britain: threats of...

Studies Confirm Private Equity Dangers

A handful of studies confirm that hospitals taken over by private equity have worse outcomes for patients.

Cholera Outbreak in Nigeria's Borno Kills 74, Infects Thousands Since May

A cholera outbreak that began in early May in Nigeria's northeastern Borno state ⁠has killed at least 74 people and infected more than 7,800, overwhelming health facilities,...

Nurses Filling Doctor Gaps: What Happens to Hard Cases?

As health systems consider shifting more physician tasks to nurses, Medscape readers focused on whether expanded care models include clear supervision, escalation, and time for patients who do not fit routine protocols.

FDA Grants Emergency Approval for Over-the-counter Drug to Treat Screwworm in Pets

The U.S. Food and Drug Administration on Thursday authorized the emergency use of a generic over-the-counter tablet ⁠to treat infestations caused by the New World screwworm...

More Nurses are Clocking in to Second Jobs

More nurses regularly take on second shifts but as the practice becomes normalized, is this best for patients?

Sandoz Files European Complaint About Chinese Antibiotic Imports

Swiss generic drugmaker Sandoz filed a draft ⁠anti-dumping complaint with the European Commission over Chinese imports ⁠of the antibiotic ingredient amoxicillin.

Recommended News For You

Pretreatment Liver Tests Often Overlooked in CDK4/6 Therapy

Does Telenursing Improve QOL in Breast Cancer?

Are Microplastics Feeding Cancer Risk?

PET-CT finds further-reaching metastases in patients with locally advanced breast cancer.

Kate Middleton Announces Major Cancer Update

PFS in R/R Mantle Cell Lymphoma is Improved by Ibrutinib-Venetoclax.

Momelotinib, a JAK inhibitor, has FDA approval to treat adult myelofibrosis in anemic patients.

Recommended Articles For You

Liquid Biopsy: A Revolutionary Tool for Early Detection and Monitoring of Colorectal Cancer 

Understanding Neutropenic Fever: What It Is and Why it's a Serious Concern  

Emerging Trends in Oncology and Precision Medicine 

Biomarkers of Hematopoietic Reserve During Repeated Physiological Stress 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

La FDA ha approvato Talzenna per trattare il cancro alla prostata metastatico che non è resistente alla castrazione.

2.

Kate Middleton Announces Major Cancer Update

3.

In postmenopausal women with hormone receptor-positive tumors, obesity increases the risk of breast cancer recurrence.

4.

Kidney cancer: Understanding what a renal cell carcinoma diagnosis means

5.

Cancer tumor anatomy influences the benefits of chemotherapy for patients with early-stage breast cancer.

1.

Subchorionic Hematoma: Causes, Symptoms, and Treatment 

2.

Respiratory Ramifications of Systemic Disease: A Comprehensive Review

3.

Understanding Pancreatic Cancer: Symptoms, Causes and Risk Factors 

4.

Uncovering the Subtle Signs of Leukemia: A Guide to Early Detection

5.

Emerging Dysregulated Signaling Pathways in Early-Onset Colorectal Cancer

1.

International Conference on Innovations in Critical Care for Oncology and Cardiology

2.

International Conference on Oncology, Cardiology and Critical Care Policy

3.

International Conference on Oncology, Cancer Prevention and Public Health

4.

International Conference on Cancer Nursing and Rehabilitation Strategies

5.

International Conference on Best Practices in Oncology, Cardiology and Critical Care

1.

Sickle Cell Disease Explained

2.

Understanding Anemia: Causes and Treatment

3.

Efficient Management of First line ALK-rearranged NSCLC - Part V

4.

Blood Clotting Disorders Explained

5.

A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot